Literature DB >> 16530396

Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests.

O O Ogunkeye1, A I Roluga.   

Abstract

The diagnostic usefulness of a single determination of serum cholinesterase activity to distinguish between overt liver disease and non-liver disease clinical problems in which a few of the traditional liver function tests are abnormal was assessed. Using three groups of subjects comprising liver disease, non-liver disease, and healthy controls, we have shown that serum cholinesterase activity helped to distinguish between liver disease and non-liver disease in subjects who had abnormality of a few liver function tests. Serum cholinesterase activity helped also to distinguish between the liver disease subjects and healthy controls. There was no statistically significant difference between the mean serum cholinesterase activities of non-liver disease subjects and healthy controls. We suggest that determination of serum cholinesterase activity is a cost-effective diagnostic means of differentiating between overt liver disease and non-liver diseases where there may be aberration of some liver function tests.

Entities:  

Year:  2006        PMID: 16530396     DOI: 10.1016/j.pathophys.2006.01.002

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  18 in total

1.  Biochemical alterations induced by Zn and Cd individually or in combination in the serum of Oreochromis niloticus.

Authors:  Özgür Firat; Ferit Kargın
Journal:  Fish Physiol Biochem       Date:  2009-06-13       Impact factor: 2.794

2.  Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.

Authors:  Bo Zhang; Cheng Shen; Jie Jin; Yi Song; Zheng Zhao; Xiaochun Zhang; Gang Wang; Yu Fan; Yue Mi; Shuai Hu; Yun Cui; Liqun Zhou; Zhisong He; Wei Yu; Wenke Han
Journal:  Int Urol Nephrol       Date:  2016-08-23       Impact factor: 2.370

3.  Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Authors:  Teppei Okamoto; Chikako Tsutaya; Shingo Hatakeyama; Sakae Konishi; Kazutaka Okita; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Tadashi Suzuki; Chikara Ohyama
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

4.  Comparative analysis of cholinesterase activities in food animals using modified Ellman and Michel assays.

Authors:  Kasim Abass Askar; A Caleb Kudi; A John Moody
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

5.  Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.

Authors:  Supriya Munshaw; Hyon S Hwang; Michael Torbenson; Jeffrey Quinn; Kasper D Hansen; Jacquie Astemborski; Shruti H Mehta; Stuart C Ray; David L Thomas; Ashwin Balagopal
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

6.  Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Authors:  Takuya Koie; Chikara Ohyama; Shingo Hatakeyama; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Tohru Yoneyama; Yuki Tobisawa; Shogo Hosogoe; Hayato Yamamoto; Masato Kitayama; Kazuyoshi Hirota
Journal:  Int J Clin Oncol       Date:  2015-07-30       Impact factor: 3.402

7.  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Authors:  Teppei Okamoto; Shingo Hatakeyama; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Takuya Koie; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

8.  Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients.

Authors:  Fanping Meng; Xiaojuan Yin; Xuemei Ma; Xiao-Dong Guo; Bo Jin; Hanwei Li
Journal:  Biomed Rep       Date:  2013-01-21

9.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

10.  Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.

Authors:  Takuya Koie; Chikara Ohyama; Jotaro Mikami; Hiromichi Iwamura; Naoki Fujita; Tendo Sato; Yuta Kojima; Ken Fukushi; Hayato Yamamoto; Atsushi Imai; Shingo Hatakeyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Masato Kitayama; Kazuyoshi Hirota
Journal:  ScientificWorldJournal       Date:  2014-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.